Adis journals embrace open access

Pharmacotherapy research is set to become vastly more accessible for all those who seek it. Wolters Kluwer Pharma Solutions, parent of the Adis family of medical journals and a leading provider of scientific information and analytics to professionals in the pharmaceutical and biotech fields, today announced it has added a new open access publishing option for authors submitting original research articles to the Adis line of pharmacology and pharmacotherapy journals — a total of 16 titles